ClinicalTrials.gg
Sign In

Dermatofibrosarcoma clinical trials

The registry lists 41 studies for Dermatofibrosarcoma across more than 10 countries. 9 are recruiting or about to start. 9 of them are mainly about Dermatofibrosarcoma (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-04.

Get an email when these change. Save the Dermatofibrosarcoma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
20
Recruiting
6
Terminated
4
Withdrawn
4
Not yet recruiting
3
Active, not recruiting
2

Phase

Phase 2
26
Phase 1
14
Phase 3
4

Where

United States
26
France
4
Canada
4
United Kingdom
4
Australia
3
Spain
3

Who runs them

National Cancer Institute (NCI) (8) · Memorial Sloan Kettering Cancer Center (3) · Children's Oncology Group (2) · Brown University (2) · Oslo University Hospital (2) · Novartis Pharmaceuticals (2) · City of Hope Medical Center (1) · St. Jude Children's Research Hospital (1)

What is being tested here

Drugs under test in Dermatofibrosarcoma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Doxorubicin135
Pazopanib114
Toripalimab101
Anlotinib101
Liposomal doxorubicin101
Peposertib101
Selinexor101
Pembrolizumab101
Imatinib005
Ifosfamide033

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 2 open · Immune checkpoint inhibitors 2 open

Coming up

0phase 3 studies under way
3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Who these studies take

Of the 6 Dermatofibrosarcoma studies recruiting now, 5 (83%) set no upper age limit and 1 (17%) stop at 75 or younger. 2 (33%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 6
AgeWomenMen
101 (17%)1 (17%)
186 (100%)6 (100%)
306 (100%)6 (100%)
405 (83%)5 (83%)
505 (83%)5 (83%)
655 (83%)5 (83%)
755 (83%)5 (83%)
855 (83%)5 (83%)

Across all 41 studies, recruiting or not: 17% stop at 75 or younger and 15% at 65; 44% take children; 2% are for women only and 0% for men only; 2% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 41 of 41. search them.